The U.S. has one of the highest maternal mortality rates in the developed world, with women of color especially at risk. Dr. Robyn R. Jones, Senior Medical Director at Johnson & Johnson, is determined to change that and find ways to address this urgent crisis.
Article
The U.S. has one of the highest maternal mortality rates in the developed world, with women of color especially at risk. Dr. Robyn R. Jones, Senior Medical Director at Johnson & Johnson, is determined to change that and find ways to address this urgent crisis.
Follows CIT’s investment in a 92-unit affordable housing complex in the redevelopment of the Watts community
Press Release
NEW YORK, Aug 3, 2020 /3BL Media/— CIT Group Inc. (NYSE: CIT) and its Healthcare Finance unit today announced a $25 million loan supporting Seavest Healthcare Properties’ acquisition of the MLK Community Hospital Medical Office Building in South Los Angeles.
Although an estimated 38 percent of the U.S. population is eligible to donate blood at any given time, less than 10 percent do so each year. The American Red Cross, a non-profit organization that provides about 40 percent of the nation’s blood, is committed to increasing the number of people who donate blood by educating Americans on the huge difference one blood donation makes in saving the lives of others.
GlobalMedic, a Canadian disaster relief charity, is distributing 55,000 pounds of aid in support of COVID-19 relief efforts in every province and territory in Canada. FedEx delivered the shipments for GlobalMedic, which included hygiene kits for more than 11,000 individuals, 4,600 liters of hand sanitizer, 22,000 surgical masks plus surgical gowns and gloves for frontline healthcare workers, disinfecting supplies and 20,000 bars of soap for First Nations communities in northern Ontario.
Months passed and the pandemic began. And then Leone, a lawyer and co-founder of a tech startup, received a call that she was a match for a 7-year-old boy who has Hodgkin lymphoma. She was asked if she was still willing to be a donor.
A preclinical study just published in Nature shows that the company's investigational vaccine has shown positive early data for eliciting an immune response against SARS-CoV-2, the virus that causes COVID-19. We share more about the findings from the recent preclinical study, along with other up-to-date information about the potential vaccine candidate.
Blog
A preclinical study just published in Nature shows that the company's investigational vaccine has shown positive early data for eliciting an immune response against SARS-CoV-2, the virus that causes COVID-19. We share more about the findings from the recent preclinical study, along with other up-to-date information about the potential vaccine candidate.
Gilead and the Satcher Health Leadership Institute at Morehouse School of Medicine announced a new partnership to develop a real-time, public-facing and comprehensive health equity data platform to help address the impact of COVID-19 and other diseases on communities of color.
The clinical trial has completed full immunizations of the company's investigational HIV vaccine regimen. Learn what this means for the future of fighting the disease—and also for the creation of a potential vaccine for COVID-19.
Blog
Since the start of the pandemic, Johnson & Johnson has been working to help address the devastating impacts of COVID-19 through the power of its science, the size of its global reach—and the know-how that comes from such experiences as standing up to challenges like HIV.
Mobilizing the Central African Republic mining community to combat the impacts of COVID-19
Blog
This piece was written by Terah DeJong, technical deputy for the U.S. Agency for International Development (USAID) Artisanal Mining and Property Rights (AMPR) project, implemented by Tetra Tech.
